Methods for purification of messenger RNA
The present invention relates, in part, to methods for large-scale purification of mRNA. The method includes, at least, steps of forming an mRNA slurry, stirring the slurry, and vacuum or pressure filtering the slurry.
1. A method of purifying at least about 1 gram of in vitro transcribed mRNA, comprising steps of:
providing a solution comprising the in vitro transcribed mRNA;
adding one or more agents that promote precipitation of the in vitro transcribed mRNA, thereby obtaining a slurry;
stirring the slurry prior to and/or while providing pressure to the slurry and/or a vacuum to the slurry sufficient to direct the slurry's mother liquor through a filter, thereby obtaining a precipitate-containing composition; and
washing the precipitate-containing composition, thereby yielding a purified mRNA precipitate;
wherein the slurry comprises at least one dispersant; wherein at least 1 gram of purified mRNA is obtained, and wherein the purified mRNA has reduced impurity of enzyme reagents used in in vitro transcription as compared to the otherwise same mRNA purified by tangential flow filtration.
2. A method for purifying at least about 1 gram of in vitro transcribed mRNA, comprising steps of:
providing a solution comprising the in vitro transcribed mRNA;
adding one or more agents that promote precipitation of the in vitro transcribed mRNA, thereby obtaining a slurry;
stirring the slurry prior to and/or while providing pressure to the slurry and/or a vacuum to the slurry sufficient to direct the slurry's mother liquor through a filter, thereby obtaining a precipitate-containing composition; and
washing the precipitate-containing composition, thereby yielding a purified mRNA precipitate;
wherein the purified mRNA has reduced impurity of enzyme reagents used in in vitro transcription as compared to the otherwise same mRNA purified by tangential flow filtration;
wherein the total purified mRNA is recovered in an amount that results in a yield of at least about 80%, 85%, 90%, 91%, 92%, 93%, 94%, or 95% or the total purified mRNA is substantially free of prematurely aborted RNA sequences and/or enzyme reagents used in in vitro synthesis;
wherein the slurry comprises at least one dispersant; and wherein at least 1 gram of purified mRNA is obtained.
3. The method of claim 1 , wherein at least the stirring step occurs in a stirred cell or in a Nutsche Filter.
4. The method of claim 1 , wherein the step of the adding one or more agents that promote precipitation of mRNA occurs in a stirred cell or in a Nutsche Filter.
5. The method of claim 1 , wherein the stirring occurs at a speed between about 50 RPM and about 500 RPM.
6. The method of claim 1 , wherein the pressure is between about 5 PSI and about 100 PSI.
7. The method of claim 1 , wherein at least the washing step occurs in a stirred cell or a Nutsche Filter.
8. The method of claim 1 , wherein the one or more agents that promote precipitation of mRNA comprises an alcohol.
9. The method of claim 1 , further comprising adding one or more agents that denatures proteins and/or keeps proteins soluble in an aqueous medium.
10. The method of claim 9 , wherein the one or more agents that denatures proteins and/or keeps proteins soluble in an aqueous medium comprise a salt.
11. The method of claim 1 , wherein the provided solution of mRNA comprises about 1 g mRNA to about 100 g mRNA, about 100 g mRNA to about 1 kg mRNA, about 500 g mRNA to about 5 kg mRNA, or about 500 g mRNA to about 2.5 kg mRNA.
12. The method of claim 1 , wherein a washing step comprises contacting the precipitate-containing composition with a first solution comprising a chaotropic salt and an alcohol.
13. The method of claim 12 , wherein the precipitate-containing composition is contacted with said first solution 1-5 times.
14. The method of claim 12 , further comprising a washing step that comprises contacting the precipitate-containing composition with a second solution that is aqueous alcohol.
15. The method of claim 1 , wherein the mRNA is cap and tail (C/T) mRNA.
16. A composition comprising a purified mRNA precipitate prepared by the method of claim 1 .
17. A pharmaceutical composition comprising the composition of claim 16 and at least one pharmaceutically-acceptable excipient.
18. A method for treating a disease or disorder comprising administering to a subject in need thereof the pharmaceutical composition of claim 17 .
19. The method of claim 2 , wherein at least the stirring step occurs in a stirred cell or in a Nutsche Filter.
20. The method of claim 1 , wherein the dispersant is added to the slurry obtained following the addition of one or more agents that promotes precipitation of mRNA.
21. The method of claim 1 , wherein the dispersant is one or more of ash, clay, diatomaceous earth, filtering agent, glass beads, plastic beads, polymers, polypropylene beads, polystyrene beads, cellulose salts, sand, and sugars.